InsidersTradesSigma
Track the 复星医药 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 复星医药 has recorded 3 insider filings. Market capitalisation: €61.4bn. The latest transaction was disclosed on 13 September 2022 (Purchase). Among the most active insiders: 董晓娴. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Fosun Pharma is a Chinese company specializing in the healthcare and pharmaceutical sector. It is listed on the Shanghai Stock Exchange (XSHG).